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Our Fair Quota: The Nobel Spirit

An artist's vision depicts the
di sruption of the heart's rhythm
that leads to sudden cardiac death.
Illustration by R.G. Michaels.
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Newsbr·efs
Allergist "s Advice Could Put Cats In A Lather
plish splash, give your
c at a bath. That's the
advice researchers are
extending to legions of cat
owners who are allergic to
their pets but refuse to part
with them.
When it comes to reliev
ing allergic reactions to cats,
a monthly bath may be far
more effective - and cer
tainly less expensive - than
the drugs and shots upon
which most cat-sensitive
patients currently must rely,
says allergist H. James
Wedner, M.D., associate pro
fessor of medicine. Wedner
directed a team of researchers
who presented the simple
method for reducing cat aller
genicity at the American
Academy of Allergy and
Immunology's annual meet
ing, held in Baltimore.
A monthly 10-minute
washing in lukewarm, dis
tilled water markedly reduced
the production of Fel 0 I,
the major allergen in cats,
the Washington University
researchers reported.
'The ideal treatment for
cat-sensitive patients who
experience symptoms of
allergic rhinoconjunctivitis,
asthma or dermatologic
reactions is to remove cats
from their environment,"
Wedner explains. "Unfortu
nately, many patients suffer
continual symptoms either
because they are unwilling or
unable to eliminate cats from
their homes."
These patients can receive
pharmacotherapy in the form
of antihistamines, deconges
tants and asthma medica
tions, or immunotherapy,
meaning allergy shots, Wedner

S
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Jazz, the shop cat at the Salty Dog grooming service of Robert
and Pam Bolton, doesn't mind a bath, despite his look. The
Bolton's regularly bathe about 20 cats and say the animals
learn to like the procedure.
notes. However, the presence
of cats in the home compro
mises the effectiveness of
both forms of treatment.
'This procedure of month
ly bathing may provide a
simple method to reduce the
allergenicity of cats for
people who can't or won't
remove cats from their
environment," he says.
The team hadn't set out to
study the effects of bathing
on cats. Rather, the study
began as an evaluation of
two drugs, Accutane and
Etretinate, for their ability to
decrease the production of
cat allergen. Neither of the
two retinoic acid derivatives
helped. However, in analyz
ing the bath water for Fel D 1
values, the researchers noticed
a significant decrease associ
ated with the washing proce
dure itself.

In a study of 10 cats, they
found a consistent decrease
in Fel 0 I production begin
ning in one cat after three
washes and in all 10 cats
after seven washes. The
amount of Fel 0 I each cat
produced varied, but the aver
age decreased from 3,031
milliunits per cat at wash
one to 400 milliunits per cat
at wash nine.
There was a marked varia
bility in Fel 0 I recovered
among the group of cats, and
also a month-to-month varia
bility in Fel 0 I recovered
from individual cats. For
example, during the first
seven washes, one cat's Fel
o I values varied from 562
to 3,632 milliunits per wash.
However, cats with initially
high levels tended to remain
relatively high, and those
with initially low levels
remained relatively low.

At the final wash, three
cats produced less than 10
milliunits and five others
produced less than 375 milli
units. Two cats produced
more than 1,000 milliunits of
Fel 0 I after nine washes, but
that still represented a signif
icant decrease from their ini
tial values.
Fel 0 I, a protein produced
by the salivary and sebaceous
glands, is deposited on the
skin and hair either as the
hair passes through the seba
ceous gland or as the cat
preens. It is a major compo
nent of the cat dander that is
ubiquitous in cat owners'
homes.
Wedner and his colleagues
are unable to explain why
monthly washing decreases
production of the allergen.
"While the washing proce
dure might be expected to
alter the skin production of
Fel 01, we wouldn't expect it
to have a significant effect on
salivary production,' he says.
"Washing 12 effective, how
ever, and that suggests the
skin may contribute more to
overall Fel 01 production
than was previously thought."
Regardless, he comments,
any strategy to reduce pro
duction of Fel 0 I would, by
decreasing its prevalence in
the environment, decrease
symptoms and suffering for
cat-sensitive patients.
As to sheer numbers of
cat-sensitive patients, there
seem to be no exact figures.
According to the American
Academy of Allergy and
Immunology, some 10 per
cent of the general popula
tion - and 20-30 percent
of asthma patients - may
be allergic to animals. And
though nobody knows why,

---'\
ca ts are more likely than dogs
to cause allergic reactions.
Cats are currem ly the m ost
popular pet in the U nited
S lates . and cat o w nersh ip
seems to be on the ups wing.
rcports th e Washington ,
D .C. -based Pet Food
Institute. C ats reside in 30
percent of the 92 .5 m illion
hom e ~ in this country. the
institute notes. Accordi ng to
its fi g ures , that translates to
57.9 m illion felin es .
Wou ld monthly bathi ng
creale, we ll. a cate rwaul ')
Probably not. says the Amer
ican Ve terinary Med ical
Association (AVMA ).
While c at washin g m ay
not be regular pract ice. it's
not that uncommon , say~
AVMA spokes person S haron
Curtis. "You alwa ys h ea r lhat
cat s take care of the msel ves.
but ['ve been hear ing more
a nd more about pco p k who
do wash th eir c ats ." As fa r as
th e ac tua l bath. reac tion s will
vary dependi ng on the age of
the cat s - the younger the y
are , the easier they adapt 
and tempe ra ment. Cu rt is
recomme nds consu lt ing a
vete rinarian for advice a bo ut
shampoos . if they are to be
used, si nce cat s can be a ll er
gic to cert a in ch em icals . S he
notes also lhat a ve t ma y
suggest tips for easi ng cat s
into the bathing rou tine .
" ' n our study. cat w a~ lles
were performed under li g ht
anesthes ia. " Wedner says.
"Cats can. ho weve r. he
train ed to accept bathing a.'
a standard procedu re, and
thi s is particular ly easy to
accom plish in kittens. Bath 
ing is not ham1ful to them
and. in fact. , how c a t ~ and
some exoti c breeds require
frequent bathing. " .

New Medical hllaging Systenl Under Develo}1Iuent

A

rt and sc ience overl ap

in a laboratory in the
Clin ical Sciences
Research Bu ilding where a
sensing system fi rst con
ceived and built as a high
tech method for producin g
fine portrait sc ulpture is
being adapted to serve the
goals of medicine . According
to M ichael W. Van ni e r, M .D. ,
professor of radi o logy at
Washington Unive rs ity's
M allinckrodt In st itute of
Rad iology, the equ ipme nt
pro mi ses to become a " brand
new tool for biomed ical
imagi ng. " A nd he says that
locating the machine was
" quit e a find."
Bearin g th e name Cenc it ,
after the firm that fi rst devel
o ped the tec hnology to carve
busts using a computer-driv
en machine tool, the device
collects a complete set of
de scrip tive data for any
surface placed within its
dome-shaped chamber. The
dome comfortably acco mmo
date s a seated person.
Earlier method s for gath
ering three-dim ens iona l data
required 15 to 90 second s to
do their work; C encit needs
only about three-quarters of a
second. In an eyeblink, s ix
cameras and six fla s htube
powered projectors mounted
in the dome combine to tri
angul a te every point on a
su rface. Each complete data
set consists of 144 fra mes
and requires nine mega bytes .
or 9 million c harac te rs, of
co m pute r storage.
Co m plicated computer
a lgo rith ms the n interpret the
data from the specialized
video came ras and rec rea te
an accurat e th ree-dim e nsion
a l im age . R ather than trans
mit th at information to pro

duce statues , Vannier and his
colleagues work with com
puter-graphics images and
color hard copy as a final
product. A ddi ng analy s is
software and carefu lly ca li
brating the syste m makes
precise measurement of any
su rface detail possible . " We
can record the surface of the
body or an y part of the body
in a frac tion of a second ,"
says Yanni er.
For the physician . suc h a
tool will relate external land
marks to intern al anatomy.
facili tating the accurate
guidance of biopsies or the
positioning of patient s for
other sca nning procedures
with up-to-the-second infor
mati o n. For the reconstruc
tive surgeon, a no-risk method
for gathering prec ise phys ical
descriptions may prove inv al 
uable. With no anesthesia
required and no ioni z ing rad i
ation invol ved. the speedy
im agi ng device may one day
find a large place in the prac 
ti ce of pediatrics as well.
"A bi g literature on th e
mathematical description of
surfaces ex ists ," says Vannier,
"but th ere are very fe w tools
for doing the work. " The
Cencit device at the School
of Medicine is o ne of four in
the world; two remain at the
parent company, a subs idiary
o f St. Louis-based C P I C or
poration, and the other is in
the ha nds of the U.S . A rm y
as a tool for guiding the
precise fit of gas masks to
the faces of it s personnel.
Collaborating with Vanni er
on projects to develop the
scanne r as a medical tool are
co-invest igator Leroy V.
Young, M .D., pro fessor of
pl astic surge ry. a nd research
eng ineer G ul ab B hatia, one

A machine-carved portrait
swiplure .vymbolizes the
purpose for which the Cencit
del'ice was originally cre
ated. Today, the high-speed
data gatherillg illstrument
;s being adapted to medical
imagillg.
of the mac h ine's developers.
The researc hers are working
toward man ip ulating images
more quic k ly, and B ha tia has
writlen software that allows
the processing of the data to
include prec ise quantitative
measuremen ts . A protoco l
also is underway to asse ss
the too l's e fficacy as an aid
to su rgic a l procedures
invo lving the fa ce and head.
W ith the project only four
m on ths o ld, the team already
is produc ing high quality
hard copy. "We are commit
ted to de ve loping an effective
tool," Van nier says.
The project is funded in
part under the M isso uri
Research Ass istance Act,
which states as it goal , "to
promote research projects
and ap pli ed projects which
will enh anc e e mplo yme nt
opportunity in M i s~ ouri,
stimulate economi c develop
ment and encourage private
invest rne nl. " Also contribut
in g funding are th e Cenc it
orporation and Washington
lni vers ity . •
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Study Shows
Best TrealluellL
For Advanced
Breast Cancer

A

lthough a larger per
centage of breast can
cer is being diagnosed
early, when treatment is most
effective, for those women
with locally advanced breast
cancer - what physicians
call stage III - the best
approach now appea rs to
be a combination of three
regimens: radiation therapy,
chemotherapy and surgery.
According to recent research
at the School of Medic ine,
the sequence in which the
individual treatm en ts are pre
scribed also may be vitally
important to success.
In the ir study of 237
women treated with various
combinations of the three
approaches over a span of
20 years ( 1968- 1987), Mary
V Graham, M .D. , and her
colleagues in the Radiation
Oncology Center at Mal
linckrodt In stitute of Radi
ology repo11 that survival
rates were sign ificantly higher
when all three treatment
options were combined. Local
contro l of tumors - preven
tio n of recurrence at the origi
nal disease site - also peaked
when systemic therapy, irrad
iatio n and mastectomy were
combined.
Though mastectomy alone
has been s hown to yield poor
results, with relapse rates as
high as 78 percent five years
after the surgery, Graham
says "mastectomy is impor
tant for local control of
tumors, even though the
movement in general has
been away from it. Some

4

times, the tumor burden is
apparently just too grea t for
alternative therapies." An
instructor in radiation onco l
ogy, Graham prese nted the
results of her study to the
annual meeting of the Amer
ican Society for Therape utic
Radiology and Oncology,
held in Miami Beach in
October, 1990.
AU of the subjects in the
retrospective study were
diagnosed as having stage III
disease, one of four classes to
which physicians assign all
breast cancers. Stage III is
characterized by a tumor five
centimeters in diameter or
larger, with skin or chest-wall
involvement or advanced
lymph-node disease.
In stage I cancer, the tumor
is less than two centimeters
in diameter, with no Iymph
node involvement and no
distant metastasis, or shifting
of th e disease. Stage II com
prises disease with tumors as
large as five centimeters or
lymph-node invol vement.
And stage IV displays metas
tases to distant sites in the
body.
According to Carlos A.
Perez, M.D, director of the
Radi ation Oncology Center
and a collaborator on the
research, a sma ller and smal
ler percentage of women
with breast cancer is being
diagnosed with advanced dis
ease - e ither stage 1Il or
stage IV "Thanks to sc reen 
ing mammography, public
awareness and physician
education, early diagnos is is
becoming more common,"
he says. Still, of the one in 10
women who will be afflicted
with breast cancer, perhaps
20 percent will be diagnosed
wi th advanced disease.
" Many of these are neglected
cases - women who did not

Mary V. Graham, M.D.
seek medical attention for
whatever reason. And some
just have aggressive tumors
that are not diagnosed until
they are more advanced, "
says Graham.
The aut hors also report on
how successful the four treat
ment modalities were in con
trollin g recurrence of cancer
at the original site five years
post-treatment. The success
rates: 31 percent - irradiation
alone, 47 percent - irradi
at ion and systemic therapy,
80 percent - irradiation
and mastectomy, and 93
percent - irradiation , mas
tectomy and systemic thera
py combined.
The investigators also
examined the effecti veness
of the treatment when the
sequence of its variou s ele
ments was taken into account.
They divided those women

who received an three thera
pies into two gro ups: one that
received mastectomy prior to
getting sys temic medication
and radiation therapy (in the
conventional order), and
ano ther that began chemo
therapy and/o r radiation
therapy before undergoing
surgery (a less traditional
approach).
Althou g h the results were
not statistically significant,
Graham reports an increase
in survival rates for women
who were treate d with chem 
otherapy and/or radiation
before they unde rwent breast
surgery. "It may be that suc
cess depends upon not just
what treatment we give, but
when," says Grah am.
Perez speculates that the
better survival rate seen when
the traditional order of thera 
pies is reversed may be due

to reduced cancer-cell acti vity at the time of the surgery.
"If we can make the cells
non-viable with early treatment, they are inactivated
before they are disseminated
by surgery," he proposes. But
he warns that a definitive
an swer to the question of
why one sequence is superior
to another will have to wait
for future studies.
Graham also plans further
investigations. She would
like to design prospective
studies that test the hypotheses presented by her first
investigation, but acknowl
edges that ethical consid era
tions will have to be weighed
carefully in light of the evi
dence that the triple modality
is the most effective and that
it may also be best to begin
chemotherapy and irradiation
before surgery.
Graham al so add s a bigger
caveat. The result s of her
study show that as therapy
becomes more aggre ssive,
the number of seriou s and
moderate complications ri ses.
In particular, chemotherapy
appears to contribute to the
number of side effects ex perienced. Irradiation alone produced complications in only
si x percent of the patient s
receiving it. Combined with
mastectomy, th e percentage
remained the same. But when
irradiation and chemotherapy
were combined, the rate went
to 33 percent. In triple modality therapy, 19 percent of
patients suffered seriou s side
effects. The li st of complications includes fractures, cardiac disease, swelling of the
arm, hemmorhage and others.
As Graham says, "The study
supports a combination of
mastectomy, radiation therapy and systemic therapy,
but at a cost." •

Fit·st Monsanto
Scholar N anled
Oderick L. McCoy
first learned of the
Washington Univer
sity Medical Scientist Training Program (MSTP) when
he was a high school student
in Santa Monica, California,
and as he says, " trying to
decide what to do with my
life. " Today, he is a secondyear student in the School
of Medicine and the first
Monsanto Scholar in the
newly established Monsanto
Scholars-Medical Scientist
Training Program for Minori
ty Students.
The award - made possi
ble through a $600,000 gift
from the Monsanto Fund 
will enable McCoy and stu
dents selected in future years
to receive paid tuition and a
monthly stipend while pursu
ing combined M.D. and Ph .D.
degrees in the rigorou s sixyear program. Monsanto
Scholars will be named annually, with the program supporting as many as six stu
dents at a time. The Monsanto
Fund is the philanthropic
branch of Monsanto Co .
"Vitally needed improvements in health demand th at
we attract the most outstand
ing young scholars of all
backgrounds to careers in
biomedical research," says
William A. Peck, M.D. , vice
chancellor for medical affairs
and dean of the School of
Medicine. "We are extremely
grateful to the Mon santo
Fund for providing Washington University School
of Medicine with a unique
opportunity to addre ss this
goa\."
R

John L. Mason, Ph.D.,
president of Monsanto Fund,
says, "Monsanto Fund has a
long-tenn commitment to
support the advancement of
science education. The scholars program at Washington
University School of Medicine allows us to nurture a
growing pool of minority
science scholars so critically
needed in the next several
decades. "

Roderick L. McCoy

McCoy is a graduate of
Stanford University, where
he majored in electrical engineering and built a strong
science background. He plans
to pursue a growing interest
in immunology and currently
works in the laboratory of
immunologist Dennis Loh,
M.D., as part of his six years
of MSTP training.
Directed by Carl Frieden,
Ph.D., professor of biochemistry and molecular bio-physics, the MSTP began at
Washington University in
1968 and is one of 29 nationwide funded by the Nation al
Institutes of Health (NIH).
The program offers outstand
ing students an opponunity

to train as academic phy si
cians with a background in
basic research. 'This is an
important program for the
medical and graduate
schools," say s Frieden. "It
attract s outstanding students
who have an interest in
research and research medi
cine." The Monsanto Schol
ars program is a way to
attract minority students to
the medical field, he adds.
At present, four minority
students are enrolled in the
MSTP.
Washington University
operates the largest MSTP in
the United States. Since 1974,
148 students have graduated
from the program and the
great majority have gone on
to careers in academic or
research institutions. Of the
72 students who have com
pleted residencies, 62 are
full-time faculty members.
Twenty-three of those indi
viduals are professors or
associate professors, 37 are
assistant professors, and two
are in structors .
Mon santo will contribute
more than $ 17.5 million to
communities worldwide in
1990 through the Monsanto
Fund and other contribution
programs operated by the
corporation and it subsidi
aries. More than $S million
of that total will be directed
to educational programs at
colleges, universities, public
high schools and elementary
schools. "Education , and
science education especially,
has been our priority emphasis during the 1980s. And it
continues to be our major
interest area into the J 9905,"
say s Mason . •
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Attention To Detail: Wah-lung
Brain Pj4~k and Choose

H

ave you ever walked
into a crowded room
and spotted a friend
by recognizing his favorite
red sweater') Maybe you
picked him out because he 's
tall or because of the way his
shoulders move when he
walks. Whether it was his
sweater, his height or the
sway of his shoulders, you
paid attention to a particular
type of visual infomlation.
The sea rch shifted your
visual system into high gear
and a remarkable process of
elimination allowed you to
sift through your surround
ings and select what you
needed to find that familiar
face.
This amazing abil ity of
the brain to select the infor
mation it needs and by pass
what it does not has interest
ed scientists for years. Only
recently have the tool s and
knowledge become available
to explore the recesses of the
brain where these routine
functions take place.
At Washington University
School of Medicine, scientists
have used PET (positron
emission tomography) to
observe activity in the brain's
visual centers as the selection
process occurs. Their study is
one of the first to identify
regions of the brain that are
relat ed to specific aspects of
vi sual attention and shows
that as attention shifts there
is a corresponding change in
blood flow patterns.
"At anyone time there is
a tremendous amount of
information coming into the
brain , but we don't use it all.
We select and ignore," says
6

"rh~),

Steven E. Petersen, Ph.D.,
acting director of the division
of neuropsyc hology. "We're
trying to learn how the brain
makes these selections 
how the information process
ing is implemented in terms
of circui try."
Petersen, Maurizio
Corbetta, M.D., research
in structor in neurology, and
their colleagues have learned
that certain parts of the visual
cortex - the area in the back
of the brain that deciphers
what the eye sees - become
active or "enhanced" when
we focus on a particular
aspect of an object, suc h as
color. They believe these
specialized areas sift through
and process selected informa
tion, thu s allowing us to pick
and choose what we look for
at any given moment.
"The purpose of the study
was twofold," Petersen says.
"First , there seem to be areas
in the back of the brain that
are related to different aspects
of vi sual objects, like color
or shape or velocity. We
wanted to identify areas
related to those thing :.. Then
we wanted to SCL: il we could
show what effect attention
has on those areas by manip
ulating what peoplc do with
the vi sual stimulus. Rather
than manipulate what went
into the eyeball, we manip
ulated what study techniqu es
people were thinking about."
Petersen and Corbetta
designed a task that required
eight subjects to watch for
different characteristics 
color, shape and velocity 
of the same objects for a
series of 40-second PET

scans. The seri es was repeat
ed every 10 minutes for about
two hours.
By observing blood flow
changes in subjects' brains
while the tasks were taking
place, Petersen and Corbett a
were able to identi fy several
overlapping visual associa
tion areas related to color,
shape and velocity that are
believed to playa role in the
process of selection.
"Different stimu li activate
different areas of the brain,"
says Corbetta. "If a st imulus
such as color is being
attended to, the frequency of
neuronal firing increases in a
specific region of the brain."
At different times , sub
jects were asked to identify
changes in a single character
istic and changes in all three
characteristics. Subjects proved
to be more sensitive to subtle
changes when they focused on

a single characteristic, Peter
sen say, which shows, "You
do better looking for one thing
than looking for several."
"Even though the visual
st im ul i were the same , when
you pay attention to a partic
ular characteristic such as
shape, what you are thinking
about turns up a certain vis
ual association area," he
ex plains. "We actually could
measure what peopl e were
thinking with PET. because
the scan or exposu re picks up
how the marker is flowing
through the brain. Blood flow
changes locally with how hard
your brain is working - how
much nerve cells are firing."
"Jf you're told to look in a
crowd for a friend wearing a
red coat, looking for the red
ness heips you find your
friend, " he says. "You are
given that information and
are able to use it. "

Maynard V. Olso1l, Ph.D. , was among the participants ill the
symposium, "Gellome Allalysis al Washingtoll Ulliversity,"
sponsored by the Center fo r Genetics ill Medicine. The sym 
posium's l'arious speakers explailled their work ill lay terms
alld related it to the recently f unded Huma" Genome Project.
The School of Medicine is one offour cellters of investigatioll
in the initiative that will eventualiy decipher the complete
genetic message of human beillgs.

I
Scientists are just beginning to understand attention,
he comments. One reason it
has captivated the scientific
audience is because it is the
cornerstone of consciousness.
"Studying attention is a
way to get close to studying
consciousness," Petersen
says. "It is studied a great
deal in the fields of psychology, philosophy and neuro
science  all are interested
in attention because it's so
relative to how we interact
with the world. It's of great
interest to curious humans in
getting closer to understanding how we become conscious
human beings . •

Patient Cured

of Ahnormal
Heart Rhytluu

A

46-year-old Illinois
woman is among the
first patients in the
nation and the first in
Missouri to be cured of an
abnonnal heart rhythm using
high-frequency, electrical
energy.
The patient was discharg
ed from Barnes Hospital on
Oct. 24. Doctors here say the
new technology may elimi
nate the need for medicine or
surgery in many patients with
certain types of heart rhythm
abnormalities.
The technique, called
radiofrequency catheter abla
tion, is being studied at the
School of Medicine under the
direction of Bruce Lindsay,
M.D., Robert Hoyt, M .D. ,
and Michael Cain, M.D.

The team of cardiologists
used a catheter in the woman's
heart to transmit high-frequency, electrical pulses to
a small portion of cardiac
tissue responsible for her
arrhythmia. Arrhythmias
arise out of short circuits
within the heart's electrical
system.
Using radiofrequency
electrical energy, the tissue
containing the errant electri
cal pathway was selectively
destroyed. The result was a
healthy heart, according to
Cain.
The advantage of radiofrequency electrical energy,
Cain says, is that the intensity and duration of the
energy transmission can be
precisely controlled, allowing doctors to selectively
destroy small portions of tissue with the same accuracy
that previously could be
achieved only with surgery.
The technology evolved
out of the expertise at the
Medical School for heart
arrhythmia treatment, which
includes medications, implantable devices that recognize
and tenninate certain abnor
mal heart rhythms, and arrhy
thmia heart surgery, which
has a near 100 percent cure
rate. The patient is among a
small number to undergo the
procedure, including those in
pilot studies at the University
of Michigan and the Univer
sity of Oklahoma.
The new therapy is an
addition to the many treatment options available and is
expected initially to benefit
patients with a type of arrhyth
mia called supraventricular
tachycardias that are associ
ated with the Wolff-Parkinson
White Syndrome . •

Waterston
Receives

$3.8 Minion
Fronl NIH
Obert H. Waterston,
. M.D., Ph .D., profes
sor of genetics and
associate professor of anato
my and neurobiology, has
received a $3.8 million grant
to develop large scale DNA
sequencing methods.
The three-year award
comes from the National
Institutes of Health's (NIH)
Center for Human Genome
Research. It supports in part
the collaborative effort between Waterston's group at
the School of Medicine and
the group of John Sulston
and Alan Coulson at the
Medical Research Council
(MRC) Laboratory of
Molecular Biology in
Cambridge , England. The
MRC will provide $1.9 million in funding.
The three-year project
will begin sequencing the
complete genetic material
(DNA) of the C. elegans
nematode, a tiny transparent
wonn. This animal is an im
portant model for studying
development and cell biology
worldwide. The project's aim
is to sequence 3 million base
pairs or, 3 percent, of the
entire DNA of the nematode.
If successful in this initial
endeavor, the groups will
expand their efforts to tackle
the total sequence. The project also involves evaluating
the effectiveness of currently
available automated sequen
cers in large scale DNA
sequencing and developing
computer software to aid in
R

handling and interpreting the
large amounts of data that
such a project entails.
Waterston has worked in
recent years on the construc
tion of the physical map of
the wonn's DNA, which
serves as the basis for the
sequencing project. He also
is recognized for his genetic
research involving muscle
development in the nematode
and recently received MERIT
status from the NIH to continue that work.

Robert H. Waterstoll, M.D.,
Ph.D.
A 1965 graduate of
Princeton University, Waterston received his M.D. and
Ph.D. in 1972 from the Uni
versity of Chicago. He served
his internship in pediatric
medicine at Chi Idren's Hos
pital Medical Center in Bos
ton and was an American
Cancer Society and Muscular
Dystrophy Association postdoctoral fellow at the MRC
Laboratory of Molecular
Biology in Cambridge. He
joined the School of Medi
cine faculty in 1976. He
returned to Cambridge as a
Guggenheim Fellow in 1985
for a sabbatical year. •
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The

ofthe Ages
By Kleila Carlson
An ornamental
initial capital from
Andreas Vesalius'
De Fabrica (1543).
considered the most
beautiful textbook
ever printed.

out of the past by Paracelsus, a spirited and
fanatical scientist whose primary interest
was treatment of open wounds, but who,
according to one report, was unable to save
himself from dying of such an injury in a
tavern brawl. (In fact, he more likely suc
cumbed to a stroke.) Another features
Georg Bartisch, who began as a barber's
apprentice and became a noted authority on
surgery and ophthalmology. Offering
insight into a quasi-scientific kind of medi
cine that once provided a roundtable for
musicians, magicians, philosophers and
astronomers, they are the rare texts - some
as old as 500 years - of the Washington
University Medical Library's archives and
rare books division.

Photograph: hy Tomlleint"
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More than 5,000 rare volumes are in
three collections recently acquired from
the library of the St. Louis Metropolitan
Medical Society . The medical society,
the oldest of its kind west of the Missis
sippi River, closed its own library earlier
this year. The School of Dental Medicine
transferred approximately 1,000 vol
umes, including a second edition of Zene
Artzney (1532) which is reported to be
the first book ever devoted strictly to
western dental therapeutics. Until the
volume was cataloged here, no copy was
known to exist in North America.
Probably the most significant coIIec
tion from the medical society is that of
Robert Schlueter, M.D., a St. Louis
physician who lived from 1872-1955.
Schlueter's Paracelsus coIIection is con
sidered the world's largest library of
works by or concerning the German
renaissance physician and philosopher
Philippus Aureolus Theophrastus Bom
bast van Hohenheim, who was known as
Paracelsus. Perhaps the most original

Two sixteenth century title pages from
works by Albertus Magnus and Realdo
Columbo.

medical thinker of the 16th century,
Paracelsus was a controversial figure
who advanced medicine by quarreling
about it. He has remained controversial
for five centuries, with a lasting effect on
the development of western thought. The
Schlueter Collection includes more than
400 titles dating from 1530 to 1970.
The James Moores Ball Collection,
rich in anatomical atlases dating from the
16th to the 18th centuries, reflects the
interests underlying Ball's scholarship as
exemplified by his biography of Andreas
Versalius and by his study of the practice
of body snatching. A St. Louis physician
who died in 1929, Ball was an avid bib
liophile and eminent member of the St.
Louis Medical Society. Approximately
400 titles compose his collection.
The General Rare Books Collection
from the St. Louis Metropolitan Medical
Society is a composite of more than
3,100 acquisitions and gifts, from a 1569
text on herbal treatments to early 20th
century works. It also includes a 1681

A renaissance book of hand-driven, wind-driven, animal-driven gears, levers and mills (1617). The double-leaved illustrations
throughout are expertly engraved in traditional renaissance architectural perspective. Such books, along with texts on warfare,
architecture, botany and other subjects add richness to medical collections.
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work by Francois Mauriceau, who is
credited with establishing obstetrics as
a separate science.
The Henry 1. McKeliops Collection
was the historical gem of the School of
Dental Medicine. McKeliops, a recog
nized leader in the profession of dentis
try and an early St. Louis practitioner,
helped organize the Missouri State Dental
Association and was its first president.
Among his volumes are 18th and 19th
century titles in French and German, as
well as works by early British and Ameri
can medical authors.

Susan Alon, rare books librarian, says
in recent months the library has amassed
works it normally would have taken
years to collect. Managing the collection
is a challenge that both overwhelms and
excites Alon, who herself is a newcomer
to the Ii brary.
"I would like to have this be a must
see for doctors bringing visitors to the
school and medical center," says Alon,
who was at the Yale Medical Historical
Library for 12 years before coming to
Washington University last April. "This
rare books collection is one thing that

.. ... t.• ·,l,I...

(Above) The anatomical plates of Pietro
Berretini were lost for more than a cen
tury, having been engraved in 1618 and
not published until 1741. Berretini's
figures are often representations of
entire bodies in action, such as this
gracefully gesturing figure set in a tra
ditional renaissance landscape.
(Left) William Cowper's Myotomia
reformata is among the most beautiful
atlases of the 18th century, employing a
fluid style of artistic anatomy in its cop
perplates, some after Rubens and
Raphael.
(Top right) From Jean Galbert Salvage'S
Anatomie du gladiateur combattant
(1812), this classic copperplate engrav
ing representing the bones and muscles
of the head and neck is an excellent
example of the intersection of art and
anatomy.
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The oldest book in the collection, the
1477 treatise Arzneibuch, by Orloloff
von Beyrlandt. To a large extent, itsfor
mat is based on that of the mediaeval
manuscript.
distinguishes this medical school from
others. There are few of these collections,
probably fewer than a dozen significant
collections in the country, but there are
many medical schools."
On the seventh floor of the library,
highlights of the collections are promi
nently displayed in glass cases along the
outer corridor of the archives and rare
books division . There , the browser can
view first and second editions of Georg
Bartisch 's writings on eye treatments,
the first work of its kind written in Ger
man; a first edition of Opera chirurgica
(1564) by Ambroise Pare, a skilled sur
geon who was considered the authority
on the subject in his day, and a first edi
tion (1569) of Girolamo Mercuriale's
work on the benefits of exercise and
medicinal hot baths.
Works not on display are stored in a
humidity-controlled vault or shelved in
an adjacent area while they await cata
loging. Alon predicts the task of defining
the collection will continue for some
time as she determines what is valuable
and what is merely old. The Homcrest
Foundation, a private charitable enter
prise in New York, has provided a three
year grant to conserve and catalog the
collections.
Although some volumes are in disre
pair, most of the works have withstood
the test of several centuries well. Many
of the books are printed on cotton rag
paper and bound with vellum or parch
ment, durable materials that increase
their longevity. "These books are in bet
ter condition after 500 years than books
produced much later," Alon says. The

A representative and emblematic title
page isfrom Casserius' De vocis audi
tuso organis historia anatomica (1600).
The illustrations contained in the text
include the first drawing of a human
tracheotomy, without anesthesia.

detail of the illustrations contained in
the texts also indicates the high quality
of the collections. In many instances,
lengthy collaboration between anatomist,
engraver and printer meant that produc
ing a single chapter required three to
four years. Alon says the illuminations
would compare favorably with any mod
em anatomy book's illustration.
No total dollar value has been placed
on the rare books collection, but in many
in stances the worth of a single volume
exceeds the library's $10,000 annual
book budget. "It is a significant resource
for this mid-continental region," Alon
says. On the average, two to five rare
books are added each year.
More important than their monetary
value is the books' great research value
and their contribution to the study of
medicine today. "The history of medi
cine is so important to the study of
medicine that it is an integral part of it,"
she says. "You would be surprised at
some of the information contained in
these older medical texts."
Paul G. Anderson, Ph.D., who heads
the archives and rare books division,
says the recently acquired collections
have fortified the library's already strong
areas of ophthalmology, obstetrics and
midwifery, brain localization and func
tion and deaf education. With the acqui
sitions, he hopes to satisfy both current
researchers and those looking at medi
cine from a totally historical perspective.
"Collections such as these make one
aware of all sorts of values thai were
important to a particular time," he says.
"Looking at obstetrics in the 17th cen

tury, we're able to infer attitudes about
women, family and children. The same is
true of warfare, battles and politics if we
read about the healing of wounds. Atti
tudes toward mental health can be
inferred by knowing more about the
notions of witchcraft and medicine."
Though the history of medicine is
very specific, Alon stresses that it is also
"very interdisciplinary," because prior to
the mid-19th century medicine was not
as specialized as it is today. "Everybody
had a philosophy of health and every
body contributed to the discussion," she
says. "Medicine was caught up in music,
magic, philosophy and astronomy .
Regardless of your subject or field of
research , I can find something in the his
tory of medicine that will have an impor
tant bearing and be of interest to your
research."
Both Alon and Anderson hope the
collections will be of interest to faculty
and staff at the hilltop campus as well as
the medical school.
"A collection only comes alive when
people use it," says Alon. "Knowledge
of the collection grows as researchers
use it. A collection is quiescent, which
this one is, because of lack of use."
The last large collection contributed
to the rare book holdings came in 1977
when Central Institute for the Deaf
donated its library on otology and deaf
education assembled by its founder, Max
Aaron Goldstein, M.D. The rare books
division was established independently
from the archives in 1974 and contains
more than 16,000 volumes . •

The Medical Library'S rare books are housed on the 7th floor of the new library
building, where rare books librarian Susan Alon looks after their care.
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L{/e ll'il/J Tlullassemia
fry Steve Kohler

hen Chris Tsangaris was just
three months old, a carefully timed
genetic switch closed deep inside the red
blood cells of his infant body. Without
so much as a click, the mechanism
turned off specific fetal genes and acti
vated their adult counterparts. The
switch - common to us all - worked
fine. But the newly activated genes did
not. And that has made all the difference
for Chris Tsangaris and the millions like
him whose lives are ravaged and short
ened by the genetic disease called tha
lassemia major.

As a result, Chris' bone marrow,
where red blood cells develop , began to
struggle and swell in a futile attempt to
make enough hemoglobin to do the oxy
gen-carrying job. His bones became thin
and brittle. The ineffective hemoglobin
damaged any normal red blood cells that
were being produced, and a dangerous
anemia plagued him.
The course of treatment: regular
blood transfusions. From the age of three
months, Chris got new, oxygen-rich
blood twice every month. Now , at 34,
he's had perhaps 750 transfusions. For
thalassemia major patients, there is no
option. Without transfusions, death is a
near certainty before the age of five .
Transfused blood brings a reprieve,
but it also carries its own cost in the
form of a heavy load of iron that cannot

Timothy J. Ley, M.D.
A tiny error in Chris' DNA, affecting
perhaps no more than a few parts in 3
billion, garbled the genetic recipe for
hemoglobin, the oxygen-carrying pig
ment of red blood cells. Lying dormant
and undetected until the switch was
thrown, the flaw then made it impossible
for Chris' blood to carry oxygen; the
hemoglobin built by his adult genes was
not put together correctly for that funda
mental task .

Thalassemia patient Chris Tangaris
prepares to receive what he reckons to
be his 751st transfusion. Assisting in
Jewish Hospital's transfusion unit is
Teresa Arb, R.N.

be removed. Chris' physician, Timothy
Ley, M.D., explains: "Thanks to transfu
sion, the marrow gets the message that
enough red blood cells are present and
backs off. Bony defects become less
severe and the anemia is alleviated. Life
becomes relatively normal until a patient
reaches his mid-teens. Then iron loading
begins to cause problems."
Most thalassemia patients require
two units of blood every month, each of
which contains 200 milligrams of iron.
A normal daily intake is a single mil
ligram. The simplest math shows the
thalassemia patient's monthly dose of
iron to be about 13 times normal. "The
body is designed to hoard iron, not to

eliminate it," says Ley, a hematologist.
Faced with such huge quantities, the sys
tem soon shunts the overload into tissue
where it does not belong.
Endocrine organs take a share of the
excess, with the result that growth and
sexual development are arrested. The
liver suffers. Often, as in Chris' case,
diabetes sets in when the pancreatic
islets are poisoned by iron. The skin
takes on a dark, bronze hue. And most
dangerous of all, the muscle cells of the
heart are damaged. If the iron loading
goes unchecked, thalassemia patients
receiving regular transfusions almost all
die before their 20th birthdays, Ley says.
Most often, the cause is heart disease.
Transfusions alone, therefore, are only a
delay, an imperfect treatment that even
tually fails.
Eliminating the iron is the second,
equally vital , half of the therapy. Ley, an
associate professor of medicine who has
studied thalassemia for his entire career
at the School of Medicine and before
that at the National Institutes of Health,
says that removing the iron is an attain
able goal. For 15 years, the drug
Desferal has been employed as an iron
chelator - a chemical compound that
binds iron into a ring within its own
molecular structure. Because Desferal is
soluble, the body secretes it, and with it
goes the undesirable iron.
Not a perfect therapy, Desferal has an
active half-life of only about 10 minutes,
so oral administration or shots are not
useful. Instead, patients wear computer
controlled pumps that deliver subcuta
neous or intravenous doses over a long
period. Usually, the treatment requires
six days of medication out of every
seven, with the pump - carried on the
belt or in a hip pocket - running for 12
hours each day. Sunday is a day of rest.
Though not restrictive, the pump cre
ates a certain presence in a young per
son's life that may be resisted or even
rejected . Chris Tsangaris has made it his
life's work to "get kids to pump," as he
puts it. He travels internationally, orga
nizing and speaking about the needs of
thalassemics; he visits families and gives
demonstrations for newly diagnosed
patients and their apprehensive loved
ones; and he'll show his own pump and
catheter to anyone who expresses an
interest in thalassemia. "The public
doesn't know, and they should," he says.
Chris' list of service to the Thalassemia
International Federation (TIF), the
Cooley's Anemia Foundation and the
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Thalassemia Action Group (TAG)
includes ex-presidencies, regional direc
torships and enough one-on-one experi
ences to shame a Larry King. He knows
the needs and fears of the thalassemic as
only another can. The people who are his
family as much as any kin could ever be,
he calls "the patients."
His best friend, a patient in Boston, is
giving a benefit dance to raise funds for
the treatment of someone who can't
afford it. Chris will fly there . He says:
"All the patients go. We get together; we
talk about our world , and we get strong.
Conferences and get-togethers are the
best things that ever happened for the
patients. When we lose a patient, every
body gets down. But if we ' re together
then we don't dwell on it; we keep
going. We keep the patients as strong as
possible - minimize the damage."
Chris' motto: "Pump until the pill,
take the pill until the cure," refers to the
development of an oral chelator that will
do what Desferal does without the need
for an expensive and complicated deliv
ery device. Such a medicine is under
development, Ley says, and effective
oral therapy is a matter of time. But a
replacement for Desferal - highly spe
cific and almost free of side effects - is
not an easy assignment.
Chris' own history with the drug is
complicated. Although he was among
the first group of patients ever to receive
Desferal, he underwent blood transfu
sions for 18 years before he ever pumped
the first drop of chelator. Now, he is one
of the oldest thalassemia major patients
in the world, and Ley is intensifying his
therapy in an attempt to get the accumu
'Iated iron out of his system.
Scientists know they can prevent the
iron build-up that plagues thalassemics.
Ley's question is: "Can we tum them
around by aggressively removing it?"
Using high-dose chelation - Desferal
delivered at three times the normal rate
- Ley treats a cadre of four older tha
lassemics in the Jewish Hospital hema
tology-oncology outpatient clinic. Over
18 months, the four have gotten no worse,
and the levels of iron they are excreting
have gone up dramatically. "Can we
reverse the consequences of years of iron
loading?" Ley asks. "Time will tell. "
Chris, who met Ley at a thalassemia
conference in Greece, runs his pump 24
hours a day, six days each week. His
experience of his disease has created an
awareness of his own health and made
him a knowledgeable student of medi

16

cine. He knows when he needs blood and
when he can get by an extra week with
out a transfusion. At the first sign of a
fever, he seeks an emergency room, and
he talks to his doctor almost every day.
For others, prospects are not so good.
In the third world, all too often finances
limit treatment The cost of administering
two units of blood is roughly $500; a
year's course of transfusions for a tha
lassemic therefore approximates $6000.
Conventional Desferal treatment costs an
equal amount. High-dose chelation
might triple that. To add a diabolical

making treatment feasible for the first
time in regions where computer-con
trolled medicine pumps are as rare as
cellular telephones . But it is not the final
resolution that Ley is looking for. He
seeks a cure, not just a palliation.
That will require corrective measures
at the molecular level - an "operation"
without a scalpel in a realm just begin
ning to open up to medical science. The
goal is to use highly sophisticated bio
chemical techniques to keep the genetic
switch from ever tripping in those who
have defective adult genes for the pro

Chris Tsangaris' activity is not restricted by either his genetic disease or its treatment.
twist to the tale, the disease is most com
mon in many parts of the world - India,
Southeast Asia, China and the Mediter
ranean basin - that can least afford to
provide care. The somewhat technical
reason: thalassemia evolved as a positive
adaptation to the malaria that plagues
those areas. According to Ley, the para
site responsible for malaria cannot thrive
in thalassemic blood cells. So those with
the thalassemic trait are resistant to
malaria, an advantage in reaching child
bearing age.
In Thailand, one percent of the popu
lation has the disease, and Greece's min
istry of health , among the world's most
enlightened on the subject, spends at
least $5,000 per year on each of the iden
tified 4,000 patients in that country. The
$20 million total rises by about a million
dollars every year.
An oral chelator will help with com
pliance and may bring costs down, even

duction of hemoglobin and also to be
able to flip it back so that fetal genes are
reactivated in thalassemia patients.
In his effort, Ley has a few things
going for him. First, thalassemia is prob
ably the best understood of the 4,000
plus human genetic diseases. Scientists
know the composition and location of
both the fetal and adult genes that con
trol hemoglobin production. Researchers
also know that fetal hemoglobin works
just fine in adult humans. "If the fetal
gene continues to produce, the adult
genes don't come on, and the person is
normal. Lots of people walking around
don't even know they're running on fetal
hemoglobin," Ley says.
Most important, perhaps, is that Ley
was part of the team that first showed the
switch could be manipulated. That suc
cess was the first time a gene ' s function
had ever been controlled from outside,
and it generated a rush of interest.

The computer-controlled and pocket-sized pump delivers chelating medication over a
period of time.

Unfortunately , the first drug - the
one found by Ley and his colleagues in
work done during 1982 to 1984 at the
NIH - is still the best. That drug , 5-aza
cytidine, is primarily a chemotherapy
agent used in the treatment of leukemia.
It reactivates fetal genes (or keeps them
active) by changing the chemical envi
ronment in which they work. It also
"tickles" the bone marrow into making
fetal hemoglobin, Ley says. The trouble
with 5-azacytidine is that the drug is
toxic to cells. It could be tested only on
critically ill patients and is not a viable
medicine for children who would suffer
under its long-term consequences. "It's
a howitzer. We have to do it with a bul
let," Ley says.
The switch that Ley wants to operate
at will "is still a black box." But people
who continue to employ fetal hemo
gllobin into their adulthoods are helping
to pry open the lid. Ley's research has
revealed that those people also have a
mutation in their DNA very near the
fetal genes. Ley has discovered that the
mutation eliminates a normal DNA
structure - a "blip" - near the genes.
When the DNA is transcribed, or used as
a recipe card, the missing blip may inter
fere with the ability of a protein to " knock
out" expression of the fetal hemoglobin
genes .
Put simply, the mutation prevents the
switch from being thrown. The blip in
the DNA points toward the proteins that
work the switch. If Ley can find those
proteins that do the switching, then he
may be able to suppress them .
Once researchers can do that, they
will be able to keep faulty adult genes
silent and inoperable. They may also be
able to reactivate fetal genes , getting
them to make viable fetal hemoglobin.
When that vision becomes reality, Chris
Tsangaris and his fellow patients will be
spared their debilitating health problems
and their transfusions, their Desferal
pumps and their terrible fmancial burdens.
Chris can look forward to that goal
and see progress , even delight in it. But
he's not much inclined to think or say "if
only." He ' s not given to dwelling on
how his life might have been different.
He says instead , "I ' ve already lived lon
ger than I should have. My mother was
told I'd never see 14. Three or four times,
I ' ve been on my way out. One day I
won't be here. That's the reality. In the
meantime, if I can do some good and be
an example, then I should do it."
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A grid imposed on
a human heart rep
resents the preci
sion with which
medical science
approaches sud
den cardiac death .
Normal rhythm and
tachycardia are
illustrated , along
with normal and
disrupted organiza
tion of the mole
cules of the heart's
membrane. The cir
cular inset at lower
left is a map of an
ischemic event: the
shaded area repre
sents the region
deprived of blood,
and the numbers
record the ensuing
delay in the flow of
an electrical wave
across the heart
muscle,
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Research Reveals the Culprits in
Sudden Cardiac Death
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M ore than 300,000 Americans 
the equivalent of the population of St.
Paul, Minnesota or Tampa, Florida - are
liable to die sudden cardiac deaths during
the next 12 months. Their lives will end
unpredictably when their hearts suddenly
stop pumping blood.
The problem sounds simple enough
- if the heart stops pumping, look to
see why. Medical science routinely treats
problems that seem to be much more
complicated. Upon autopsy, however,
the heart muscles of sudden cardiac
death victims often appear perfectly nor
mal; no trail is left for medical detectives
to follow. And because of the quick and
unpredictable nature of the event, only a
few cases have ever been recorded as
they occurred. Both of those factors,
added to the complex nature of what
really happens when a heart suddenly
stops, have made investigations espe
cially difficult.
But a decade of research by Peter B.
Corr, Ph.D., and his colJeagues at Wash
ington University School of Medicine
has finally revealed the chain of events
that occurs in many sudden cardiac
deaths . The researchers also have identi
fied the weak link in that chain, the point
at which it soon may become possible to
interrupt the process and save the life.
"It's an electrical problem," says
Corr, who is developing a therapeutic
agent that foils the process before it can
proceed to its tragic conclusion. The
cleverly conceived drug will lie in a
potential victim's system until the changes
that precede an electrical disruption of
the heart's rhythm activate it. Then it
will work to forestall the "short circuit"
of the heart's electrophysiology and the
resulting irregular hearbeat, or arrhyth
mia, that is the real killer, according to
Corr's investigations. It may be a decade
before such a drug is available, Corr says.

Major contributions to various aspects
of the work have been made by Jeffrey
E. Saffitz, M.D., associate professor of
pathology and medicine; Kathryn
Yamada, Ph.D., research assistant pro
fessor of pathology and medicine;
Richard W. Gross, M.D., Ph.D., associ
ate professor of medicine; Burton E.
Sobel, M.D. , Tobias and Hortense Lewin
Professor of Cardiovascular Diseases,
and a large contingent of students and
post -doctoral fellows .
THE ('HAIN OF' EVENTS

T he most common scenario in sud
den cardiac deaths involves the follow
ing series of events, says Corr, a profes
sor of medicine and pharmacology.
First, as a sort of trigger, blood sup
ply to the heart is sharply reduced. The
presence of coronary artery disease lead
ing to a sudden clot within a vessel is the
usual starting point.

For the deadly arrhythmia to occur,
the change must be abrupt. "If you close
off a major supply artery to the heart
very slowly, no disruption of the beat
will result, because the electrical abnor
mality in the heart tums out to be rela
tively uniform. Reopen the vessel
slowly, within a narrow time frame, and
everything goes back to normal," says
Corr. Cells deprived of blood for a long
time - 30 minutes or more - usually
will die. But if the effect is distributed
evenly over the heart muscle, arrhyth
mias do not occur, Corr explains. "The
key to sudden cardiac death as a result of
arrhythmia is the heterogeneity (or
unevenness) of the effect on the heart,"
he says.
When the vessel supplying a region
of the heart is obstructed and the normal
quantity of blood is sharply reduced , sci
entists say the region becomes ischemic,
or deficient in blood. In ischemia, events
occur rapidly. Oxygen levels plummet,
the biochemical balance of the heart's

Peter B. Corr, Ph.D ..• at the high pressure liquid chromatograph, or HPLC. The
device makes possible precise separation of the many lipids in tissue and cell samples.
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Medical student Kevin Donahue monitoring equipment that produces ischemia, then records the resulting electrical changes in
muscle cells in vitro.
muscle cells, called myocytes, is upset,
and the electrical wave that controls the
regu lar pumping action of the heart is
disrupted. When the normally smooth
now of that electrical wave is disturbed,
the heart's rhythm races as electrical
impulses re-enter the loop too soon, trig
gering extra beats. The condition is called
tachycardia.
Finally, in just a few minutes of clock
time, the heart can go into fibrillation. Its
contractions become chaotic, totally dis
unified. Corr says the heart then resem
bles "a bag of worms," all wriggling
independently, and no more pumping
action occurs. It is this arrhythmia, the
result of upset electrical impulses, that is
the killer, says Corr.
"The key question," he says, "is 'why
does the electrical behavior change so
drastically?' What happens to the wave
to destroy its uniformity?" To answer
those questions, Corr calls upon the sym
bol of a wave on the ocean as it encoun
ters a small island. Where the land
intrudes on its flow, the wave's regular
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ity is interrupted. The wave breaks, and
its pieces encircle the island irregularly,
looping back on the main swell and clos
ing on all sides of the land. In an
ischemic cardiac event, the electrical
wave moving over the delicate mem
brane of the muscle cells is the equiva
lent of the sea, and the region deprived
of blood is like the island. But there is an
added complication: the island moves.
"The area of electrical disruption within
the ischemic region is not necessarily
static; with each beat it can change,"
adding to the condition's unpredictabil
ity and disunity, Corr says.
ORIC~IN:

OF , RRHY rUM}

T hat image describes what happens
but not why it happens. To understand
the mechanisms at work , Corr conducted
research on individual myocytes and also
on the living hearts of humans and lab
animals in which he tracked and mapped
electrical impulses as they crossed heart
cell membranes.

Those membranes are made largely
of lipid, or fat, molecules. Their highly
ordered form is the grid for the electrical
impulse that originates at the heart's
sinus node, then sweeps across the organ,
controlling the beat. An interval in which
the heart refills with blood follows before
the impulse is regenerated to guide the
next beat. When the precise organization
of those molecules is disturbed, Corr
says, the impUlse that travels across
them also becomes disordered. Simply
put, he has traced the arrhythmia that
kills so many to organizational alter
ations in the heart's membrane.
The heart is a huge user of energy and
unusual in its preference for compounds
called fatty acids as fuel. Deep in the
workings of the individual myocytes,
oxidation converts fatty-acid molecules
to energy at a tremendous rate, Corr
says. So harmful events resulting from
the initial ischemic episode occur at a
rapid pace.
Two elements called metabolites 
players in the complicated oxidation pro

cess - tum out to be the culprits. The
two have separate origins but similar
chemical structures, Corr says.
Known as LCA (for long-chain acyl
camitine) and LPC (for Iysophosphatidyl
choline), the metabolites accumulate
when the heart is deprived of blood and
oxygen. LCA occurs normally at very
low levels in the heart's cells as a trans
porter of fatty-acid fuel across the mem
brane surrounding a cell's energy-pro
ducing component. During ischemia,
when dropping oxygen levels upset the
biochemical balance, LCA is no longer
efficiently cleared from the system.
Corr's figures show that within two min
utes of the onset of an ischemic event,
LCA rates increase three-fold.
LPC is derived from another source:
blood cells, the vasculature or the cell
membrane itself, Corr is not certain
which . The problem in tracing it has
been that it is so common it seems to
come from everywhere, he says. But it,
too, is part of a heart cell's metabolism.
Four enzymes normally break it down,
but the actions of two of them are blocked
by LCA, and a third's activity is reduced
as acidity increases.
One of the effects of a reduced oxy
gen level is acidification. Therefore,
as LCA levels increase and the heart
becomes more acid, three of the four
enzymes that nonnally clear LPC are
disabled. As a result, its levels rise "two
to three-fold within three minutes of the
onset of ischemia," says Corr.

When the two metabolites become
overabundant, they collect in the care
fully ordered structure of the cell mem
brane, for which they have a chemical
affinity, Corr says. Accumulating there,
they disturb the membrane's structure,
disrupting the integrity of the wave that
flows across it and - in short order
inducing an arrhythmia.
Corr has recorded the increased pres
ence of the metabolites in the mem
branes of individual cells and biopsies
from heart tissue, and he has measured
the electrical potential across both nor
mal, control cells and their ischemic
counterparts, determining that accumula
tion of the metabolites is largely respon
sible for the abnormal electrical activity
induced by ischemia.

HYTHMIA

In

untreated animals with blocked
arteries that caused ischemic zones in the
heart, Corr recorded similar membra
nous increases in LPC and LCA.
However, in animals that had received a
new drug - POCA - that works to foil
the production of the two arrhythmia
causing metabolites, he found no such
increases. By suppressing the enzyme
that produces LCA, POCA prevented the
accumulation of both metabolites and
precluded both tachycardia and fibrilla
tion in all of the animals studied. Corr
writes that inhibiting the enzyme offers a

"promising approach" for preventing
"sudden cardiac death that typicall y
occurs very soon after the onset of acute
ischemia in man."
Unfortunately, he says, POCA in its
present form is not a viable therapeutic
medicine. Because it works to inhibit an
enzyme that is prevalent in the body , its
effect is too broad. Commenting on the
work, Steven SedJis, M.D., agrees:
"POCA's toxic side effects limit its use
fulness," he says. Nonetheless, Sedlis, an
assistant professor of medicine at New
York University School of Medicine,
says Corr's research, "has shown that the
levels of these two metabolites are
higher in ischemic hearts than in con
trols. In addition, in those ischemic
hearts that develop arrhythmias the lev
els are higher than in those that do not.
Even more exciting is his work with
drugs that reduce the amount being pro
duced . Such a metabolic inhibitor could
make a big dent in the number of sudden
cardiac deaths."
Corr is presently developing a drug
that avoids POCA's side effects by
virtue of its speci ficity for ischemic tis
sue. The drug' s design puts to work the
knowledge that blood-deprived tissue
quickly becomes acidic. His goal is to
create an enzymatic inhibitor that will be
active only in acidic environments.
Sedlis calls such a medicine "feasible,"
and says the concept is "an exciting way
of activating the drug only at the site
where it is needed."
As physicians become more adept at
identifying people at risk for heart
attacks and especially sudden cardiac
death, they may soon be able to pre
scribe such a drug as a precaution.
lncorporated in the system and silent
until it is required, the drug will be acti
vated by the increased acidity associated
with an ischemic event. Then, its action
of inhibiting the production of LPC and
LCA will be invoked, and the two dis
ruptive metabolites will not be overpro
duced. Despite the ischemia, the regular
electrical wave controlling the heartbeat
will continue, and tachycardia and fibril
lation may be averted.
And, as the only outward sign of all
this investigation and intervention, a siz
able portion of the terrible number of
sudden cardiac deaths will be prevented.
In the words of Sedlis,"To me, that
sounds revolutionary. " .

Three leads from the same human heart display a classic picture of ventricular
tachycardia, or abnormally rapid heartbeat.
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Otw Rtir quota: The Nobel Spirit
By Marion Hunt

I"

Herbert Gasser, M.D., left, and Joseph Erlanger, M.D.
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A

t the April 1915
dedication of the
Medical School's
new buildings Robert
Brookings voiced the hope
" that we will add, through
research activities , our fair
quota to the sum of the
world's knowledge of medi
cine." In the 75 years since,
three generations of faculty
have contributed to that
goal. But those who have
won Nobel Prizes in physi
ology and medicine belong
in a special category. No
other recognition brings with
it such glory, and the School
of Medicine takes justifiable
pride in its Nobel laureates.
Six of the 15 Nobel laure
ates who have been affiliated
with the School of Medicine
either were trained here or
did their prize-winning work
here.
These outstanding scien
tists served as inspiring
teachers to new generations
of researchers - transmit
ting excellence beyond the
boundaries of this institution .
In 1944, Philip Shaffer
(then Dean of the Medical
School) wrote that when
Professors Joseph Erlanger
and Herbert Gasser became
the first faculty members to
win the Nobel Prize in phys
iology and medicine for
work done at the Medical
School : "the question was
repeatedly asked : 'How did
St. Louis and Washington
University manage it?"
Answering his own ques
tion, Shaffer continued: " We
like to believe that the high
honors bestowed upon our
illustrious colleagues reflect
a spirit and a policy that this
university has consciously
cultivated: a policy to seek
for its staff those likel y to

Earl Sutherland, M.D.
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Daniel Nathans, M.D., left, with Oliver Lowry, M.D., Ph.D.
see fundamental problems
and to be able to divine ways
to solve them . The spirit
comes when such men and
women labor together and
thereby stimulate each other."
Shaffer's comments
proved accurate and prophet
ic, because only three years
later, in 1947, a second
Nobel Prize in physiology
and medicine came to Wash
ington University Medical
School faculty members:
Carl Cori and Gerty Cori
were noti fied that they
would receive the prize
jointly for work on the cat
alytic metabolism of glyco
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The story of Washing10n Unil el'sit,"s
first Nobel laureates sho\\s seientifie
eollaboration to be the "dt'lieate
operation'~ Carl Cori onee ealled it.
1

gen. The adverb "jointly"
was of special importance;
not only had the Coris
worked together for 24
years, but they had done so

despite opposition to their
collaboration. As a woman
scientist, Gerty Cori faced
particular obstacles.
After finishing medical

school in Prague, the Coris
had married in 1920 and
emigrated two years later.
Fortunately, in 1931,
Philip Shaffer was wise
enough to recruit Carl Cori
as head of pharmacology
and arrange for a research
position and "token salary"
for his wife in the same
department. (Gerty Cori was
promoted to full professor in
1947 , the year she won the
Nobel Prize). Far from feel
ing any resentment at the
disparity in their rank, Carl
Cori later wrote that this
offer seemed remarkable to
him: "Then many universi

ties had rules against employ
ment of two members of the
same family." While their
academic rank differed, what
counted was continuing their
scientific collaboration with
out added constraints.
Not only did Carl and
Gerty Cori work together in
brilliant harmony , but they
created an intellectual atmo
sphere that attracted a new
generation to science. Among
them was Arthur Kornberg
who came to work with
them in 1947 because, "It
was the liveliest enzymology
lab in the world, a haven for
ambitious, gifted people
from all over." Kornberg
joined the faculty in 1953,
serving for six years as head
of microbiology. He shared
the 1959 Nobel Prize in phys
iology and medicine for his
work on DNA replication.
Years later, he recalled that
in 1947, Gelty Cori drew his
attention to Oswald Avery's
paper on DNA, saying sim
ply: "You must read this; it
is very important." Once
again, the generous spirit of
scientific synergy that Shaffer
cited in 1944 led to a new
line of research, and another
Nobel Prize.
Only 12 years later, yet
another graduate of the Cori
laboratory (and the Wash
ington University School of
Medicine) won the Nobel
Prize in physiology and med
icine for his discovery of
cyclic AMP: Earl Sutherland.
A member of the class of
1942, he began to work in
the Cori's laboratory while
still a medical student and
took a fifth year of study to
devote more time to research.
He later recalled, "Those
early years in the Cori lab
gave me the opportunity to
work with a number of out-

Arthur Kornberg, M.D.
standing investigators. Carl
Cori gave me a living exam
ple of clear thinking."
The story of Washington
University'S first Nobellau
reates indicates that scien
tific collaboration is indeed
the " delicate operation" Carl
Cori once called it. Joseph
Erlanger and Herbert Gasser
mastered the art of making
differences complementary
rather than adversarial. The
senior partner, Erlanger, was
"the firm leader of bright
people converging on excit
ing research." He had been
Herbert Gasser 's professor
of physiology at the Univer
sity of Wisconsin; as Gasser
later remembered, Erlanger

was "such a beautifully clear
lecturer. ..the subject matter
he presented amounted to a
revelation." Like his mentor,
Herbert Gasser received his
M.D. at Johns Hopkins , and
in 1916 he joined him in St.
Louis.
In 1921, the year Gasser
was made head of pharma
cology, they presented their
first paper using a cathode
ray device to record from
nerve fibers . The equipment
was so sensitive to vibration
that their work was done at a
concrete bench resting direct
lyon the earthen floor in the
South Building's basement.
Their colleague, George
Bishop, recalled: "These two

men were not particularly
sophisticated in either elec
tronics or physics, and their
troubles were various and
cumulative." While collabo
ration demanded painstaking
cooperation, differences
remained between them
because, according to Hallo
well Davis, "they did not
always share the same inter
pretation of their own obser
vations." Nonetheless, they
"respected one another's
view, and each held to his
own friendly di sagreement."
In 1936, Gasser wrote: "We
have long since agreed to
disagree as the smoothest
way of carrying on this col
laboration." To maintain
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Carl Cori, M.D., and Gerty Cori, M.D.
basic differences and mutual
respect was no easy task.
Like the Coris, Erlanger
and Gasser inspired the work
of a new scientific genera
tion - collectively, they
were called "axonologists"
because they concentrated on
neurophysiology. Working
in laboratories across the
country, their leadership
centered at the School of
Medicine. In 1944, Helen
Tredway Graham described
a crucial aspect of their
intellectual style. A faculty
wife (married to Evarts
Graham), she was among
Gasser's first appointments

in pharmacology. A gifted
scientist, she observed her
mentor keenly: "To Doctor
Gasser, an integral aspect of
research is discussion, and in
those days discussion seemed
never to weary him. Many
were the hours spent over
endless cups of coffee in the
physiology seminar room, in
the cafeteria in friends'
houses, or in restaurants; and
many were the diagrams
drawn on odd envelopes, on
cafeteria checks, on paper
napkins, or even on restau
rant tablecloths."
Whether by discussion,
instruction, or collaboration,

since 1944 the Nobel spirit
has continued to flourish
here . In 1978, Daniel
Nathans, class of 1954,
shared the Nobel Prize for
"the discovery of restriction
enzymes and their applica
tion to problems of molecu
lar genetics ." Tracing his
scientific interests to a sum
mer's work as a second year
student with Oliver Lowry
in pharmacology, Nathans
has said that there he learned
"the joy of research" which,
he adds, "became a model
for my own relationship
with students." Thus, the
Nobel spirit inspired by out

standing medical-school fac
ulty members is transmitted
to a new generation .
Perhaps Carl Cori best
described this school's
unique quality in analyzing
his decision to come here 60
years ago: "Physiology , bio
chemistry, and pharmacol
ogy were housed in one
building ... it has been claimed
that there was something
mysterious about this build
ing which made for success.
Actually, it was the spirit of
the school, its organization,
and its faculty which were
largely responsible."

Student Stage
.tetiug Up
by Brad Snyder
cannot imagine a more
exciting time to enter the
medical professi on. Wit h
the century drawing to a
close, we are compelled to
look forward into a ne w era.
As the ne west generation of
physicians, we are charged
with setting the goals of our
profession and finding solu
tions to the health-care con
cerns that currently challenge
our society.
Unfortunately, while we
are faced with forging new
solutions and systems to
meet multiple medical chal 
lenges, we must also confront
the frustration of implement
ing change in a conservative
profession and an often unre
sponsive and insen siti ve gov
ernment. Indeed, this frustra
tion has led to an unparallel
ed era of health -care activism
by a lay public. t :nfortunate
Iy, this activism is often
poorly co,ltrolled and ulti
mately counter-productive.
In lieu of the educated.
considered opinions of
health-care professi onals, the
leading voices of health-care
activism are too oft en those
of extremist zealots. While
the commitment of these
activis ts is commendable, the
inherent contradiction in the
violent destruction of research
labs by animal rights groups,
the bombing of reproductive
health clinics and abuse of
clinic patrons by anti-abortion
acti vists , and the disruption
of a scientific conference by
CT-UP ( a group of AI DS
activi sts known for their
radical tac tics) has discred

I

ited the respect ive voices of
these activists.
Although these violent
demonstrations effectively
focus attention on the issues ,
the attention is equivalent to
our focus on terrorist attacks.
These groups do not typically
offer constructive solutions
to the issues, but when they
do, their proposals are dis
counted as the vehement
rantings of crazed radicals.
Certainly, we do not want
the health-care policies of the
future to be dictated by such
health-care terrorists.
We need more moderate
and con sidered acti vism to
constructively advance the
solutions mandated by the
issues. We must remember
that attention can be focused
by other means. Concerned
physicians discussing issues
with friends and colleagues,
constituents expressing their
concerns to legi slators, the
const ructive contributions of
ACT-UP developing social
programs which support
people with AIDS-these all
represent effective contribu
tions to altering policies. But
certainly, these methods do
not galvanize public attention
and media coverage to the
same extent as more sen sa
tional protests.
Peaceful demonstrations
and civil disobedience focu s
public attention with equal
intensity as more violent and
destructive protests, but with
out the counterproductive
effect. The 1989 March for
Women's Lives attracted an
estimated 600,000 partici-

Brad Snyder, M.D.
pants and represented a
respected accomplishment
for the abortion rights move
ment. This demonstration
was remarkable not only for
its size, but for its organiza
tion and order as well. Ci v iI
disobedience, such as nuclear
war protests at the Nevada
Nuclear Test Site, focuse s
public attention without
violating the intrinsic integ
rity of the argument or the
participants. The concerns
expressed by activi sts and
the solutions they offer are
more credible when the
forum is non-violent and
non-destructive.
We are obligated to get
involved. As the newest gen
eration of physicians, we
have a vested interest in
seeing that the solutions to
current and future challenges
are medically and ethically
viable. To ensure this we
must contri bute a construc
ti ve and educated voice to
the activist movements.
With our education comes
a social dut y to take stands

on health-care issues.
Clearly, our commitment
transcends the immediacy of
the physician-patient rela
tionship. We must also
contribute as active commu
nity leaders addressing the
spectrum of health-care
concerns. Invest yourself in
the future of our profession
and get involved by contri
buting your voice to health
care activism. Discuss the
issues with your neighbors
and colleagues; lend profes
sional credibility to the
arguments that you support.
If physicians don't lend a
constructive voice to the
debate, only the voices of the
health-care terrorists will be
heard . •

Editor's Note
The allthor, Brad Snyder,
MD., graduated from
Washington Unil'ersiry
Sch ool of Medicine in th e
Spring of1990. He is cur
rently serping a one-year
term as th e presidel1l of the
American Medical Student
Association (AMSA), after
which he will heg in his
residency
The 30,000-member
AMSA publishes New Phy
sician ma gazine, where this
column first appeared in the
OC/ober, 1990 issu e (Vol. 37 ,
Number 7) Outlook thanks
the publishers for permission
to reprint Snyder's thought
fulopinions.

Sil onette

A

s recently as 20 years
ago, ostomy patients
were treated with less
than fully developed surgical
techniques and nagged by
social stigmas. Often, they
couldn't even get the health
care products they needed
from uninterested manufac
turers. In SI. Louis, that
gloomy picture began to
brighten when surgeon Sam
Schneider "grabbed a sur
gery resident by the scruff

health-care products and
educates a surgeon in the
colon and rectal specialty
each year via what is one of
only 25 nationally approved
fellowships. Kodner, who
today is associate professor
of surgery and director of
the division of colon and
rectal surgery at Jewish
Hospital, calls the 20-year
evolution " a true example
of consumerism. Pressure
from patients resulted in

Ira}. Kodner, M.D.

of the neck," took him to a
group meeting of ostomy
patients and asked, "Why
don't you do something to
help these people?"
The resident whose neck
scruff was grabbed that
evening was Ira 1. Kodner,
M.D., and the grabbing
worked. It provided the seed
for what has grown into a
regional center for colon and
rectal surgery that provides
the best possible care, trains
nurse specialists, consults
with manufacturers of
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better surgical techniques,
better training and help from
manufacturers. "
Perhaps. But the combi
nation of nurturing care and
delight in a chalJenge that
characterizes Kodner's
nature also has been instru
mental. He brought the divi
sion out of that germ of an
idea and grew it into an
active group of three full
time faculty members who
investigate cancer, inflam
matory bowel disease, and
the basic changes in the

physiology of the intestine
due to aging. The group's
large experience treating
sphincter injuries establishes
its members as experts in the
field.
Beyond providing first
rate care to those who need
it, Kodner's concern broad
ens to include work on what
he calls "the real quality
control of American medi
cine." He explains: "Every
specialty, from family prac
tice to psychiatry, has a cer
tification process that is
supervised by two national
bodies . Their existence is
unknown to the public, and
it shouldn't be."
The two components of
the quality control team
Kodner speaks of are, first,
the Residency Review Com
mittee of the American
Medical Association that
scrutinizes residency pro
grams and certifies those
that adequately train special
ists . Second comes the sys
tem overseen by the Ameri

can Board of Medical Spe
cialties. Members of each
specialty select a board to
create and administer an
examination that tests for
current knowledge and tech
niques. Only those residents
who have completed an
approved residency are eligi
ble to take the examination;
only those who pass the rig
orous assessment of their
skills and knowledge
become board certified in
that specialty.
It is the second arena in
which Kodner is particularly
active. He says, "All of this
is done strictly by volun
teers ; the 20 boards are com
posed of physicians who
have practices and teaching
responsibilities . The general
surgery board, for example,
requires 38 days each year
for six years. Just to main
tain adequate standards of
care."
Kodner knows that from
experience. He sits on rhat
American Board of Surgery,

where he helps to define
what constitutes proper
training for U.S. surgeons.
And he is the recently
elected president of the
American Board of Colon
and Rectal Surgery, a similar
board for his own spec ialty .
With characteristic self-de
precation, Kodner says,
"A fter 10 years on the board
writing the examination,
updating it and administer
ing it, now I'm the president
- now I can appoint some
one else to do the work."
But clearly he's kidding ,
because in the next breath he
adds, "Washington Univer
sity has had deep representa
tion on these bodies that
make policy for medicine in
the United States. I was
lucky to be on the general
surgery board when Sam

Wells (Bixby Professor of
Surgery and chairman of the
Department of Surgery at
Washington University
School of Medicine) was its
president. And it really is
exciting; most other coun
tries do not even have ceI1i
fication programs." Kodner's
work leading the board of
colon and rectal surgery dur
ing the next year will involve
creating a recertification
program to insure "the main
tenance of excellence," as he
puts it. Robert Fry, M.D., a
partner, a member of the
division and a good friend,
calls Kodner's contributions
to the boards, "outstanding."
A way from the office and
the operating suite, Wash
ington University remains an
important part of Kodner's
life. His undergraduate

degree was earned here, and
he got hi s M.D. from the
School of Medicine. He
served his internship at Jew
ish Hospital and fini shed his
surgery residency there in
J 974. His wife is an alumna
of the business school; one
daughter is enrolled in the
drama program, and a
daughter-in-law studies
health care administration at
Washington University. A
second daughter is a student
at Ladue High School (with
two years to go until she can
be considered for admis
sion), and Kodner' s son is a
medical student at Washing
ton University School of
Medicine . "My son did hi s
undergraduate work at Har
vard; he's the black sheep of
the family," Kodner says.
In concert with the theme

of both nurturing and thriv
ing on challenge. Kodner
and his family also raise
orchids - not a pot here and
a pot there, but SOO-plus
plants of many varieties in
a greenhouse attached to the
family home. Fry says the
greenhouse is "the envy of
all his friends. I'm not an
orchid person, but this is
spectacular."
That interest, established
now for 27 years, began as a
way to keep alive a family
tradition of gardening. Kod
ner and his wife first culti
vated African violets.
Though violets are not the
easiest plants to grow and
test the skills of most horti
culturists, for the Kodners
the challenge was soon met
and interest subsequently
waned. When Kodner's wife
made him a gift of orchid
plants, the new enthusiasm
was born.
Why would a surgeon
also find lasting excitement
in flowers? Kodner has pon
dered that question and says
the two interests may be
halves of a single whole.
"When you grow orchids,
you select perfection; you
start with a plant that is
already beautiful. The sur
geon takes the imperfect and
brings it back as close to
perfect as he can ."
By saying that, he reveals
at least one of the forces
that compel his life. Whether
the subject is flowers, an
individual patient'S care or
the quality controls operat
ing on American medicine,
pushing the limits of the
possible toward perfection
is Kodner's aim . •
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The Alumni Report
Josellh Ruwitch
Leads Ahunni
Associaf on
oseph F. Ruwitch, Jr. ,
M.D. ' 66, became the
new president of the
Medical Alumni Association
this past July.
He assumes the position
from Roger L. Mel!, M .D.
'65, chief of the division of
orthopedic surgery at St.
Luke's Hospital.
Ruwitch is an assistant
professor of clinical medi
cine and maintains a private
practice of cardiology. He
joined the teaching staff of
Washington University as an
instructor in 1974 and one
year later was named as
assistant professor of medi
cine in the cardiovascular
division.
Since 1987, he has been a
liaison cardiologist in the
USA-USSR Exchange in the
cardiopulmonary area, under
the auspices of the National
Heart, Lung, and Blood Insti
tute. He has visited the Soviet
Union twice as a guest of the
USSR Ministry of Health to
meet with Soviet cardiolo
gists involved in epidemio
logical research similar to
that taking place here.
From 1984 to 1989,
Ruwitch was a member of
the admissions committee for
the School of Medicine, also
involved in medical school
recruitment and helping to
redefine admissions goals.
Ruwitch says he is willing
to work for the alumni asso
ciation because he has always
felt a "kinship toward Wash
ington University" and
because his practice is conve
niently within the university
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Joseph F. Ruwitch, Jr., M.D.
environment. As president,
he is anxious to see the alum
ni association continue to
expand its current function of
providing scholarship support
to students. He is particularly
interested in increasing the
number of endowed scholar
ships, which are named for
recognized faculty members

or alumni and funded by the
alumni association. There are
currently eight scholarships
and the association hopes to
allocate funding for a n addi
tional eight.
During his hours aw ay
from the medical school ,
Ruwitch enjoy s trout fishing
in Colorado and Yellowstone

National Park and recently
has taken up golf.
R uwirch has one son and
one daughter, and his wife ,
Sammy, currently is enrolled
in the maste r 's program in
early ch ildhood education at
Washington niversity. She
teaches at the nursery school
on the uni versity's main
campus . •

CLASS NOTES

'40s and '50s
James Hawkins, M.D.

'49, has been practicing
internal medicine at the
Tucson VA.M.e. for ten
years and plans to retire in
February 1991.
Joseph V. Sharrotta,
M.D. 'SO, retired from the
private practice of internal
medicine and cardiology on
January 1, 1990. He contin
ues to do volunteer work with
Gideons International and the
Baptist General Conference.
Theodore Feierabend,
M.D. '51, retired in October
1989. From 1952 to 1986 he
was a medical missionary to
India and was professor of
plastic surgery at Christian
Medical College in Ludhiana,
India from 1967 to 1986. He
then went to Kabul, Afghan
istan and trained the first two
plastic surgeons in that coun
try from 1986 to 1989 and
established the Department
of Plastic Surgery at Kabul
University.
A. Martin Lerner, M.D.
'54, recently took office as
governor for the Michigan
chapter of the American Col
lege of Physicians (ACP). As
ACP governor, he represents
more than 2,000 Michigan
internists to the national ACP
and oversees membership
activities. Lerner is clinical
professor of internal medi
cine at Wayne State Univer
sity School of Medicine in
Detroit. A specialist in infec
tious diseases, he is in pri
vate practice in BinTlingham,
Michigan.
James E. Darnell, Jr.,
M.D. '55, has been appoint
ed to the new position of vice

president for academic affairs
at The Rockefeller Univer
sity in New York City. As
such, he serves as the univer
sity's chief academic officer.
He has been at The Rockefel
ler University since 1973,
where he investigates the use
of viruses to study the mech
anisms of gene expression in
animal and human cells.
Ruth S. Gurd, M.D. '57,
is now emeritus professor of
biochemistry at Indiana Uni
versity School of Medicine.
She now resides in Albuquer
que, New Mexico.
Lawrence C. Pakula,
M.D. '57, recently received
the Pediatrician of the Year
A ward and Leadership A ward
from the Maryland chapter of
the American Academy of
Pediatrics. Currently in pri
vate practice, Pakula was
president of the Maryland
chapter from October 1986
until July 1989.
James F. Wittmer, M.D.
'57, has been elected as a
vice president of ITT Cor
poration and continues as
director of health, environ
ment and safety for that finn .
In May, 1990, he was also
elected to the board of direc
tors of the American College
of Occupational Medicine.

'60s
James Jekel, M.D. '60, is
the e.E.A. Winslow Profes
sor of Public Health at Yale
University and spends his
time in teaching and research
in epidemiology and public
health. He has been married
for 32 years, has four chil
dren and one grandchild.
John P. Christy, M.D.
'63, is currently the president
of the Missouri Chapter of
the American College of

Surgeons. Christy, of Poplar
Bluff, will serve a one-year
term.
Larry Holder, M.D. '68,
practices radiology and
nuclear medicine in Balti
more as a partner in a group
of 26 diagnostic radiologists.
He also serves as chief of
radiology at the Children'S
Hospital and Center for
Reconstructive Surgery there
and directs the nuclear medi
cine department at The Union
Memorial Hospital. An assis
tant professor of radiology in
the Johns Hopkins School of
Medicine, he has recently co
authored a text, Primer of
Sectional Anatomy, with MRI
and CT Correlation. Married
to Washington University
alumna Nancy Kauffman
Holder (BA '64, MSW '66),
he and his wife have three
children.

70s and '80
Robert G. Harmon,
M.D., M.P.H. '70, is admin
istrator of the Health Re
sources and Services Admin
istration. Hannon had been
director of the Missouri
Department of Health since
January 1986, as well as clin
ical professor in the Depart
ment of Family and Commu
nity Medicine at the Univer
sity of Missouri/Columbia
School of Medicine.
Dennis Cooper, M.D.
'71, is one of four Phoenix
area physicians honored for
his teaching in the premedi
cal program at Arizona State
University. He also received
the 1990 Teacher of the Year
A ward from the house staff
at Scottsdale Memorial Hos
pital. Cooper, an ophthal
mologist, has been in private
practice since 1977.

Charlotte Jacobs, M.D.

'72, is the newly appointed
senior associate dean of edu
cation at Stanford University.
This year she was awarded a
Presidential Citation from the
Head and Neck Society , the
Rambar Award for Outstand
ing Patient Care and the
Bloomfield Award for Inno
vation in Teaching.
Nicholas B. Cooper,
M.D. '78, reports that his
wife, Elizabeth, gave birth to
twins John Lee and Caroline
on August 17, 1990.
Carol Nelson, M.D. '78,
F.H.S. '81, and Keith Henry,
F.H.S. '81, live in White
Bear Lake, Minnesota. They
have three children. Nel.son
practices primary care medi
cine at Group Health, Inc.
Henry is an AIDS specialist
at Ramsey Clinic in St. Paul.
Robert E. Bechtold,
M.D. '79, is associate profes
sor of radiology at the
Bowman Gray School of
Medicine at Wake Forest
University. Hejoined the
Department of Radiology at
Bowman Gray as assistant
professor in 1984.
W. Grant Stevens, M. D.
'80, F.H.S. '86, is the associ
ate medical director of the
Marina Breast Center at
Daniel Freeman Hospital in
Marina del Rey , California.
He is a board-certified plastic
and reconstructive surgeon .
Brian C. Organ, M.D.
'81, is assistant professor of
surgery at Emory University
School of Medicine. He is
married to Stefani Cardwell.
Erika Dale Schuster,
M.D. '83, is an obstetrician/
gynecologist in Portland,
Oregon. She returned to the
U.S. in June 1989 after a
year traveling in Southeast
Asia and the South Pacific.
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Thomas Chelimsky,
M.D. '83, has been appoint
ed assistant professor of neu
rology and director of the
autonomic laboratory at Case
Western Reserve University
in Cleveland.
Edward S. Rollins, M.D.
'84 and Susan Rollins, M.D.
'84 have moved to Johnson
City, Tennessee. Edward is a
radiologist and Susan is a
pathoIogist.
Gary R. Collin, M. D.
'85, is continuing his resi
dency in surgery at Mercy
Catholic Medical Center out
side of Philadelphia, with
planned specialization in
trauma.
Nancy Bartlett, M.D. '86,
this year began an oncology
fellowship at Stanford
University.
Justin Starren, M.D. '87,
has joined PA Consulting
Group at its North American
headquarters in Highstown,
New Jersey , where he will
work as senior consultant in
the company's electronics
group . Prior to joining PA
Consulting, Starren was affil
iated with the department of
radiology at Columbia-Pres
byterian Hospital in New
York, where he directed the
design and programming of
computerized uroradiology
courseware. As part of a joint
research venture between
Siemens Medical Systems
and Mallinckrodt Institute
of Radiology, he worked on
software that enhances 3-D
image processing in cardiac
positron emission tomography.
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Gladys F. Barker, O.T.

, 38, is one of ten individuals
to receive the OASIS (Older
Adult Service and Informa
tion Sy stem) award presented
by the SI. Louis Post-Dispatch
and KMOX radio. The award
recognizes outstanding vol
unteer contributions to the St.
Louis community. Barker's
contributions include leading
and coordinating groups for
OASIS and originating and
conducting state sales for the
benefit of Miriam School in
SI. Loui s.
Karen S. Flam, O.T. '83,
and Terry Kirschner were
married April 30,1989. They
live in Boca Raton, Florida.
Flam is the assistant director
of occupational therapy at
Sunrise Rehabilitation
Hospital.

Bonnie Helfgott Fisher,
H.A.P. '85, has been appoint
ed in-house general counsel
for Pitt County Memorial
Hospital, Greenville, North
Carolina.
John M. Chamberlain,
H.A.P. '85, has been appoint
ed medical staff liaison and
chief development officer
for Glenwood Regional Med
ical Center in West Momoe,
Louisiana.
Marilyn Gruen, H.A.P.
'86, and her husband, Doug
las Majewski, announce the
birth of their son , Daniel
Jordan Majewski. They live
in Los Angeles, California.

retired as professor emeritus
from Emory University
School of Medicine Depart
ment of Pediatrics after 31
years . She was director of the
Grady Hospital Pediatric
Emergency Clinic and assis
tant chief of service of pedi
atrics at Grady when she
retired. She will be a consul
tant pediatrician for both
Florida and Georgia Child
ren' s Medical Services.
Bruner and her husband ,
John Judson Bruner, have
two children.
Robert Maltz, M.D.,
F.H.S. in medicine, serves
on the executive council at
the University of Cincinnati
College of Medicine, the fac
ulty advisory committee at
the University of Cincinnati,
and as a member of the board
of governors of that institu
tion 's alumni association.
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Bruner, F.H.S. '56-'58,

L

MEDICAL

U

M

N

CLASSES OF '36, '41, '46, '51, '56, '61, '66, '71, '76, '81
Reunion

1991

Mark your calendars!
May 2, 3,4
Further infonnation will follow.
Washington University Medical Center Alumni Association
Campus Box 8049
660 S. Euclid Av enue
St. Louis, Misso uri 63110
(314) 362-8278
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Medical scientists may have devised a way to interrupt the chain of
events that leads to sudden cardiac death - a chain that includes
the tachycardia, or abnormally rapid heartbeat, recorded by this
monitor. See page 18.
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The holiday season at Washington University Medical Center opened
with the St. Louis Children 's Hospital LOI'e Light Festival. This year,
2,400 tiny white lights decorate the buildillg and grounds.

